Ted Monohon

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ted Monohon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted Monohon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Chief Accounting Officer & VP Common Stock 27,440 $25,794 $0.9400 06 Mar 2023 Direct

Insider Reports Filed by Ted Monohon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 06 Mar 2023 1 -$1,834 4 Chief Accounting Officer & VP 06 Mar 2023, 17:55
QNCX Quince Therapeutics, Inc. 01 Feb 2023 1 $0 4 Chief Accounting Officer & VP 02 Feb 2023, 17:32
QNCX Quince Therapeutics, Inc. 05 Dec 2022 1 -$1,181 4 Chief Accounting Officer & VP 07 Dec 2022, 16:37
QNCX Quince Therapeutics, Inc. 06 Sep 2022 1 -$2,493 4 Chief Accounting Officer & VP 08 Sep 2022, 17:58
QNCX Cortexyme, Inc. 29 Jun 2022 1 $0 4 Chief Accounting Officer & VP 01 Jul 2022, 17:03
QNCX Cortexyme, Inc. 06 Jun 2022 1 -$4,770 4 Chief Accounting Officer & VP 08 Jun 2022, 16:13
QNCX Cortexyme, Inc. 03 Mar 2022 1 $0 4 Chief Accounting Officer & VP 04 Mar 2022, 16:58
QNCX Cortexyme, Inc. 14 Dec 2021 1 $0 4 Chief Accounting Officer 05 Jan 2022, 15:39